|
|
||||||||
The Annals of Thoracic Surgery, Vol 23, 14-19, Copyright © 1977 by The Society of Thoracic Surgeons
JF Ray 3d, DA Tewksbury, WO Myers, FJ Wenzel and RD Sautter
A prospective experiment was carried out in 56 patients undergoing coronary
artery revascularization to determine whether those having a
glucose-insulin-potassium (GIK) perfusion during the procedure would have
fewer myocardial infarctions (MI) compared with patients given a control
perfusion of Normosol-R. Six patients (11%) developed an MI, defined as a
24-hour creatine phosphokinase MB isoenzyme value of 100 IU per liter or
greater. Four (13%) had control perfusions and 2(8%) had GIK perfusion. One
MI in a double-graft recipient who had GIK perfusion occurred because of a
technical surgical error; therefore, the corrected MI rate was 13% in
control patients compared with 4% for the GIK group. These data, as well as
the more frequent spontaneous defibrillation in patients who had GIK
perfusion, suggest that GIK was of benefit.
ARTICLES
Can the frequency of myocardial infarction be reduced during coronary artery operations
This article has been cited by other articles:
![]() |
W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |